News Archives - Page 13535 of 13551

1 minute read

Takeda’s Hereditary Angioedema Treatment Prevents Attacks In Kids Below 12 Years

July 1, 10:28 AM

Takeda Pharmaceutical Co Ltd (NYSE: TAK) announced late-breaking data from the Phase 3 SPRING study presented at the European Academy of Allergy and Clinical Immunology Hybrid Congress 2022.

TAK

1 minute read

Global
News

EU’s Von Der Leyen Says Russia Deliberately Cutting EU Off Gas

By Benzinga Newsdesk

July 1, 10:26 AM

- Reuters

RSX

1 minute read

B. Riley Securities Maintains Buy on PennyMac Mortgage, Lowers Price Target to $18

By Benzinga Newsdesk

July 1, 10:25 AM

B. Riley Securities analyst Matt Howlett maintains PennyMac Mortgage (NYSE:PMT) with a Buy and lowers the price target from $21 to $18.

PMT

1 minute read

RBC Capital Maintains Sector Perform on Enanta Pharmaceuticals, Raises Price Target to $67

By Benzinga Newsdesk

July 1, 10:23 AM

RBC Capital analyst Brian Abrahams maintains Enanta Pharmaceuticals (NASDAQ:ENTA) with a Sector Perform and raises the price target from $64 to $67.

ENTA

2 minute read

Netflix Crashes As ‘Stranger Things 4’ Volume 2 Goes Live: Was Vecna To Blame?

By Phil Hall

July 1, 10:19 AM

Talk about bad timing: Netflix (NASDAQ: NFLX) crashed earlier this morning shortly after the final two episodes of its hit series "Stranger Things 4" went live.

DIS

1 minute read

Craig-Hallum Maintains Buy on II-VI, Lowers Price Target to $80

By Benzinga Newsdesk

July 1, 10:17 AM

Craig-Hallum analyst Richard Shannon maintains II-VI (NASDAQ:IIVI) with a Buy and lowers the price target from $85 to $80.

IIVI

2 minute read

Earnings

Micron Technology Earnings Perspective: Return On Invested Capital

By Benzinga Insights

July 1, 10:12 AM

According to Benzinga Pro, during Q3, Micron Technology (NASDAQ:MU) earned $2.63 billion, a 16.04% increase from the preceding quarter. Micron Technology also posted a total of $8.64 billion in sales, a 10.99% increase since Q2.

1 minute read